Key Takeaways
- A quarter defined by external shocks: Finished goods sales volume fell 23% QoQ as a sharp duty hike on crude vegetable oils and a 30% drop in paint-sector demand hit simultaneously, compressing margins and forcing the company to absorb costs to defend market share.
- Isostearic acid is the near-term margin bridge: Exports to Europe and the US have begun, and management expects isostearic acid to become "substantially higher than 10%" of sales next year, driving EBITDA margins to 12%–15% from April 2025.
- A new 40,000-tonne product offers a step-change, but not soon: The company is the fourth globally to develop the technology, yet manufacturing yields are not ready; management refuses to give a timeline, warning that rushing would risk "massive cash loss."
- The duty structure is an existential overhang: With raw materials taxed at 27.5% and competing finished goods at 7.5%, management calls it a "losing battle" and has made a government representation, but a reversal is a hope, not a plan.
- What to watch next quarter: Whether isostearic acid export volumes ramp as promised, any movement on the duty differential, and any sign of paint-sector demand recovery.
The Twin Shocks: Duty Hike & Paint Demand Collapse
- Duty structure inverted overnight: In September 2024, the government raised customs duty on crude vegetable oils, a key raw material, from 5.5% to 27.5%, while finished product imports remain at 7.5%. The company absorbed most of the cost increase to retain its two-thirds domestic market share, substantially damaging the bottom line.
- No import duty change for fatty acids: The duty hike forced the company to cut raw material purchases. Local sourcing does not solve the problem because domestic suppliers themselves import and pass on the duty.
- Paint sector volume collapsed 30% QoQ: Demand for linoleic acid and soya fatty acid from the paint industry, already declining from Q1 to Q2, fell a further 30% in Q3. Management says it has not lost any buyers and attributes the weakness to broader sector conditions.
- Dimer acid under Chinese dumping pressure: The company is not making money in Dimer because of dumping from China, forcing it to price at competitor levels to hold market share.
- Representation made, reversal uncertain: The company has formally represented the duty issue to the government. Management "has a feeling that at some stage things would change" and that the government "won't be able to continue like this forever," but no timeline or signal of action exists.
Nahoosh Jariwala: "Whatever the thing what we projected was based on normal market situation. Right now, in fact if you will see that our raw materials what we buy attract 27.5% duty and against that if I want to import the finished product, the import duty is 7.5%. So we are fighting a losing battle."
Isostearic Acid: The Margin Recovery Engine
- Fourth player globally, exports underway: The company has started exporting isostearic acid to Europe and the US, the world's two largest cosmetics markets. Export share rose to over 14% of revenue this quarter, up from under 10% in all prior quarters, driven primarily by isostearic acid.
- Customer approvals are slow but sticky: Approvals take extended periods because the product goes into cosmetics where buyers run lengthy trials. Japanese buyers have been in process for one year and still need approximately six more months. Once approved, business is long-term.
- Every quarter expects sales growth: More approvals are coming from different companies, and the company had visitors from five countries in the prior week. Management expects high export volumes on a continuously quarter-to-quarter basis.
- Margin uplift is explicit and near-term: With isostearic acid scale-up, management confirmed EBITDA margins can reach 12%–15% from April 2025 onwards, calling 12%–13% "easily" achievable. Isostearic acid will be "substantially higher than 10%" of total sales next year.
- Capacity utilization first, expansion later: The first priority is reaching full capacity utilization on already-installed capacity. No expansion is planned for the next 2–3 years.
Nahoosh Jariwala: "For isostearic acid, we are the fourth player in the world."
The 40,000-Tonne New Product: A Deliberate, Distant Bet
- Fourth in the world, but not yet competitive: The company has developed technology for a new product with 40,000-tonne capacity, making it the fourth globally. Product quality matches global standards, but manufacturing cost and yields are not yet at the right level.
- Management refuses to rush: A wrong yield would cause "massive cash loss" that would take time to rectify. The company is deliberately not setting a timeline, with management stating that giving a date would be "lying."
- Market entry will be gradual: Even once the company decides to proceed, entering a market with three entrenched incumbents means buyers will not shift overnight. The company cannot start at 100% capacity utilization.
- Long runway even after go-ahead: Once the decision is made, plant construction takes 1–2 years, plus one product cycle of approximately 1.5 years, with full capacity within three years of go-ahead. At full utilization of 40,000 tons, sales would double.
- A separate, smaller new product is closer: A pilot plant with 1,000 MT/year capacity has sent samples for pre-approvals. The company is the first in India and third or fourth globally for this product. Commercialization is expected in FY26, though no firm date was given.
Nahoosh Jariwala: "Yes, I am dreaming I can do it tomorrow or me just saying a timeline that I'll do it by so and so date or so and so date, it's not really possible. In that case, I'm just lying."
Rajen Jhaveri: "Like it is a simple assumption that you have to give 1000 days for any new product to be stabilized in the market."
Market Share & Competitive Dynamics
- Paint sector: share held, demand absent: The company has not lost any buyers in the paint sector. Management says competitors make inferior-grade products, and the volume decline is purely a demand-side issue.
- Dimer: pricing to survive: The company is not making money in Dimer because of Chinese dumping. It prices at competitor levels to hold market share, acknowledging that no buyer will pay a premium when lower-priced alternatives exist.
- Price renegotiation is not an option: When asked about renegotiating prices given the 20% duty disadvantage, management deflected, stating that in B2B markets, renegotiation of that magnitude is not possible.
- Grasim approval secured: Material has already been approved at Grasim and the company is selling to them, providing one anchor customer for the new product.
Nahoosh Jariwala: "Yes, obviously. What can I do? Otherwise I'll lose the market. No one is going to buy at a higher price from me. If they are able to get it at a lower price."
Financial Mechanics & Disclosures
- Forex gain is structural but immaterial: Every quarter generates a small forex gain because the government fixes the shipping bill rate below the prevailing USD/INR rate, and since the company sells on credit, rupee depreciation creates a gain. The amount is "very insignificant" and reported within other income. Management declined to quantify it.
- Export share rising: Export share rose to over 14% this quarter from under 10% in all prior quarters up to September, driven by isostearic acid. Management expects further improvement going forward.
- Product-wise breakdowns withheld: Management declined to provide Q3 and 9M revenue contributions for individual products (linoleic soya fatty acid, Dimer, Isostearic), citing that multiple products come from the same raw materials.
- Prior projections withdrawn: Internal projections of ₹735 crore revenue for FY25 and ₹979 crore for FY26 with 23.8% EBITDA margin, made long before the duty changes and demand drop, "don't hold good" and require complete reworking.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin recovery | 12%–15% EBITDA margin driven by isostearic acid scale-up | From April 2025 (next financial year) |
| Isostearic acid sales mix | "Substantially higher than 10%" of total sales | Next year (FY26) |
| Isostearic acid export volumes | High volumes on a continuously quarter-to-quarter basis | Ongoing from Q3 FY25 |
| New product (1,000 MT/year) commercialization | Commercial launch | FY26 (no firm date; "very hopeful") |
| New product (40,000-tonne) go-ahead decision | No timeline given; yields and cost not yet competitive | Indefinite; plant construction 1–2 years post-decision, full capacity in 3 years |
| Isostearic acid capacity expansion | No expansion planned | For next 2–3 years |
| Duty structure reversal | Company has made representation; hopes for policy reversal | No timeline; management "has a feeling" government cannot continue current structure forever |
| Paint sector demand recovery | Depends on broader industry revival | No timeline given |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue from operations | ₹114 cr, declined 23% YoY |
| EBITDA | ₹8 cr, declined 61% YoY |
| EBITDA margin | 6.87% |
| Net profit | ₹3.54 cr |
| Revenue from operations (9M FY25) | ₹417 cr, declined 10% YoY |
| EBITDA (9M FY25) | ₹38 cr, declined 20% YoY |
| EBITDA margin (9M FY25) | 9.21% |
| Net profit (9M FY25) | ~₹21 cr |
| Finished goods sales volume | Declined 23% QoQ; value declined ~18% QoQ |
| Share of four prime products in total sales value | 78%, versus 76% in Q2 and 75% in Q1 |
| Volume drop in paint sector (linoleic acid) | 30% QoQ from Q2 to Q3 |
| Export share of total sales | 14%, up from less than 10% in prior quarters; isostearic acid contributed 8–10 percentage points of total sales |
| Isostearic acid buyers with regular supply | 7–8 out of ~50 buyers in various approval stages |
| Dimer acid domestic market share | ~two-thirds |
| Working capital drawal | Less than ₹50 cr outstanding against ~₹130 cr of inventory and receivables; undrawn drawing power ~₹60–65 cr |
| Long-term debt | Zero |